Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherCARDIOVASCULAR PHARMACOLOGY

Effects of the Glucocorticoid II Receptor Antagonist Mifepristone on Hypertension in the Obese Zucker Rat

John C. Clapham and Nicholas C. Turner
Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1503-1508;
John C. Clapham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas C. Turner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 282 no. 3 1503-1508
PubMed 
9316865

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received July 22, 1996
  • Accepted April 8, 1997
  • Published online September 1, 1997.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. John C. Clapham and
  2. Nicholas C. Turner
  1. Department of Vascular Biology, SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Hertfordshire AL6 9AR, U.K.
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: January 1999 to September 2023

    AbstractFullPdf
    Jan 1999010
    Apr 1999124
    May 1999061
    Jun 1999010
    Jul 1999010
    Aug 1999110
    Nov 1999100
    Dec 1999021
    Jan 2000010
    Feb 2000020
    Apr 2000100
    May 2000011
    Jun 2000010
    Jul 2000110
    Aug 2000104
    Sep 2000011
    Oct 2000020
    Nov 20001526
    Jan 2001023
    Feb 2001041
    Mar 2001032
    Apr 2001031
    May 2001453
    Jun 2001113
    Jul 2001021
    Aug 2001054
    Sep 2001013
    Oct 2001241
    Nov 20010116
    Dec 2001138
    Jan 2002042
    Feb 2002485
    Mar 2002245
    Apr 2002020
    May 2002175
    Jun 2002044
    Jul 2002146
    Aug 20021911
    Sep 2002115
    Oct 2002021
    Nov 2002131
    Dec 2002252
    Jan 2003135
    Feb 2003042
    Mar 2003116
    Apr 2003168
    May 2003042
    Jun 2003222
    Jul 20038127
    Aug 20039111
    Sep 20038303
    Oct 20038239
    Nov 200311232
    Dec 20039132
    Jan 200411343
    Feb 20048215
    Mar 2004145810
    Apr 200415294
    May 200416307
    Jun 200416467
    Jul 2004164110
    Aug 200415278
    Sep 200412334
    Oct 200414317
    Nov 20045358
    Dec 200472925
    Jan 200513287
    Feb 200516232
    Mar 200521278
    Apr 20052254
    May 20056278
    Jun 200510298
    Jul 20053163
    Aug 20054198
    Sep 20054213
    Oct 20052215
    Nov 20055253
    Dec 20054211
    Jan 20069196
    Feb 20065317
    Mar 20062163
    Apr 20061209
    May 20062123
    Jun 20062121
    Jul 2006164
    Aug 2006651
    Sep 2006366
    Oct 20062159
    Nov 2006044
    Dec 20063113
    Jan 20074108
    Feb 2007365
    Mar 20070167
    Apr 20073147
    May 2007293
    Jun 20074133
    Jul 20074172
    Aug 20073145
    Sep 2007184
    Oct 20075114
    Nov 20073118
    Dec 2007533
    Jan 2008256
    Feb 20084118
    Mar 20085125
    Apr 2008684
    May 2008393
    Jun 20087166
    Jul 200841215
    Aug 2008494
    Sep 2008383
    Oct 2008785
    Nov 20083125
    Dec 2008432
    Jan 20093144
    Feb 20099108
    Mar 20094127
    Apr 20095155
    May 2009673
    Jun 20093107
    Jul 20092106
    Aug 2009101
    Sep 20095101
    Oct 20099149
    Nov 2009574
    Dec 20097104
    Jan 2010483
    Feb 20104164
    Mar 2010370
    Apr 201013112
    May 20103105
    Jun 20104108
    Jul 2010463
    Aug 2010596
    Sep 201011111
    Oct 2010087
    Nov 2010488
    Dec 20100103
    Jan 2011196
    Feb 2011226
    Mar 2011897
    Apr 2011744
    May 2011667
    Jun 2011395
    Jul 20119710
    Aug 20117610
    Sep 20113812
    Oct 201151611
    Nov 2011458
    Dec 2011433
    Jan 2012166
    Feb 20126114
    Mar 201213137
    Apr 20127912
    May 2012699
    Jun 2012896
    Jul 20122157
    Aug 20124511
    Sep 2012142
    Oct 20121325
    Nov 20126310
    Dec 2012538
    Jan 2013628
    Feb 20137510
    Mar 2013522
    Apr 2013586
    May 2013596
    Jun 2013004
    Jul 20132124
    Aug 2013014
    Sep 20132713
    Oct 20131122
    Nov 2013441
    Dec 2013273
    Jan 2014226
    Feb 2014335
    Mar 2014493
    Apr 2014325
    May 2014408
    Jun 20141133
    Jul 20148610
    Aug 2014245
    Sep 2014117
    Oct 2014038
    Nov 2014431
    Dec 2014611
    Jan 2015032
    Feb 2015434
    Mar 2015432
    Apr 2015421
    May 20151243
    Jun 2015703
    Jul 2015655
    Aug 2015239
    Sep 2015663
    Oct 2015527
    Nov 2015044
    Dec 201512132
    Jan 2016654
    Feb 2016624
    Mar 2016314
    Apr 2016212
    May 2016014
    Jun 20169916
    Jul 20164323
    Aug 20164219
    Sep 20161594
    Oct 2016222
    Nov 2016247
    Dec 2016011
    Jan 2017003
    Feb 2017051
    Mar 201711216
    Apr 2017043
    May 2017085
    Jun 20171106
    Jul 2017096
    Aug 20170114
    Sep 2017044
    Oct 2017137
    Nov 2017093
    Dec 20170124
    Jan 2018094
    Feb 20184113
    Mar 2018295
    Apr 2018077
    May 2018065
    Jun 201821011
    Jul 2018064
    Aug 2018019
    Sep 2018142
    Oct 2018286
    Nov 2018086
    Dec 20181405
    Jan 2019400
    Feb 2019110
    Mar 2019340
    Apr 2019200
    May 2019800
    Jun 2019513
    Jul 2019800
    Aug 2019400
    Sep 2019200
    Oct 2019400
    Nov 20191101
    Dec 2019401
    Jan 2020100
    Feb 2020300
    Mar 2020900
    Apr 2020523
    May 2020311
    Jun 2020600
    Jul 20201611
    Aug 2020404
    Sep 2020300
    Oct 2020100
    Nov 2020400
    Dec 2020300
    Jan 2021110
    Feb 20211231
    Mar 2021710
    Apr 20211210
    May 20212210
    Jun 20211902
    Jul 20211810
    Aug 20211710
    Sep 2021221
    Oct 2021310
    Nov 20211310
    Dec 2021500
    Jan 2022510
    Feb 2022610
    Mar 2022010
    Apr 2022920
    May 2022310
    Jun 2022700
    Jul 20221810
    Aug 20221220
    Sep 2022810
    Oct 2022210
    Nov 2022210
    Dec 2022510
    Jan 2023910
    Feb 20231310
    Mar 20231100
    Apr 20231020
    May 2023610
    Jun 2023610
    Jul 2023710
    Aug 2023210
    Sep 2023510

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 282, Issue 3
    1 Sep 1997
    • Table of Contents
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Effects of the Glucocorticoid II Receptor Antagonist Mifepristone on Hypertension in the Obese Zucker Rat
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    OtherCARDIOVASCULAR PHARMACOLOGY

    Effects of the Glucocorticoid II Receptor Antagonist Mifepristone on Hypertension in the Obese Zucker Rat

    John C. Clapham and Nicholas C. Turner
    Journal of Pharmacology and Experimental Therapeutics September 1, 1997, 282 (3) 1503-1508;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    OtherCARDIOVASCULAR PHARMACOLOGY

    Effects of the Glucocorticoid II Receptor Antagonist Mifepristone on Hypertension in the Obese Zucker Rat

    John C. Clapham and Nicholas C. Turner
    Journal of Pharmacology and Experimental Therapeutics September 1, 1997, 282 (3) 1503-1508;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Methods and Materials
      • Results
      • Discussion
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • TAS-301, an Inhibitor of Smooth Muscle Cell Migration and Proliferation, Inhibits Intimal Thickening after Balloon Injury to Rat Carotid Arteries
    • Identification of Low Molecular Weight GP IIb/IIIa Antagonists That Bind Preferentially to Activated Platelets
    • Differential Contribution of Angiotensinergic and Cholinergic Receptors in the Hypothalamic Paraventricular Nucleus to Osmotically Induced AVP Release
    Show more CARDIOVASCULAR PHARMACOLOGY

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics